Literature DB >> 28283223

Interferon regulatory factor signaling in autoimmune disease.

Bharati Matta1, Su Song1, Dan Li1, Betsy J Barnes2.   

Abstract

Interferon regulatory factors (IRFs) play critical roles in pathogen-induced innate immune responses and the subsequent induction of adaptive immune response. Dysregulation of IRF signaling is therefore thought to contribute to autoimmune disease pathogenesis. Indeed, numerous murine in vivo studies have documented protection from or enhanced susceptibility to particular autoimmune diseases in Irf-deficient mice. What has been lacking, however, is replication of these in vivo observations in primary immune cells from patients with autoimmune disease. These types of studies are essential as the majority of in vivo data support a protective role for IRFs in Irf-deficient mice, yet IRFs are often found to be overexpressed in patient immune cells. A significant body of work is beginning to emerge from both of these areas of study - mouse and human.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autoimmune disease; Cell signaling; Interferon regulatory factors; Pathogenesis

Mesh:

Substances:

Year:  2017        PMID: 28283223      PMCID: PMC8033540          DOI: 10.1016/j.cyto.2017.02.006

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  170 in total

1.  Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci.

Authors:  Eli A Stahl; Soumya Raychaudhuri; Elaine F Remmers; Gang Xie; Stephen Eyre; Brian P Thomson; Yonghong Li; Fina A S Kurreeman; Alexandra Zhernakova; Anne Hinks; Candace Guiducci; Robert Chen; Lars Alfredsson; Christopher I Amos; Kristin G Ardlie; Anne Barton; John Bowes; Elisabeth Brouwer; Noel P Burtt; Joseph J Catanese; Jonathan Coblyn; Marieke J H Coenen; Karen H Costenbader; Lindsey A Criswell; J Bart A Crusius; Jing Cui; Paul I W de Bakker; Philip L De Jager; Bo Ding; Paul Emery; Edward Flynn; Pille Harrison; Lynne J Hocking; Tom W J Huizinga; Daniel L Kastner; Xiayi Ke; Annette T Lee; Xiangdong Liu; Paul Martin; Ann W Morgan; Leonid Padyukov; Marcel D Posthumus; Timothy R D J Radstake; David M Reid; Mark Seielstad; Michael F Seldin; Nancy A Shadick; Sophia Steer; Paul P Tak; Wendy Thomson; Annette H M van der Helm-van Mil; Irene E van der Horst-Bruinsma; C Ellen van der Schoot; Piet L C M van Riel; Michael E Weinblatt; Anthony G Wilson; Gert Jan Wolbink; B Paul Wordsworth; Cisca Wijmenga; Elizabeth W Karlson; Rene E M Toes; Niek de Vries; Ann B Begovich; Jane Worthington; Katherine A Siminovitch; Peter K Gregersen; Lars Klareskog; Robert M Plenge
Journal:  Nat Genet       Date:  2010-05-09       Impact factor: 38.330

2.  Evidence for genetic association and interaction between the TYK2 and IRF5 genes in systemic lupus erythematosus.

Authors:  Anna Hellquist; Tiina M Järvinen; Sari Koskenmies; Marco Zucchelli; Christina Orsmark-Pietras; Linda Berglind; Jaana Panelius; Taina Hasan; Heikki Julkunen; Mauro D'Amato; Ulpu Saarialho-Kere; Juha Kere
Journal:  J Rheumatol       Date:  2009-06-30       Impact factor: 4.666

3.  No evidence for genetic association of interferon regulatory factor 1 in juvenile idiopathic arthritis.

Authors:  Mark S Fife; Laura Gathercole; Emma M Ogilvie; Carmel J W Stock; Lisa F Mack; Rachelle P Donn; Wendy Thomson; Patricia Woo
Journal:  Arthritis Rheum       Date:  2007-03

4.  Response of human intestinal lamina propria T lymphocytes to interleukin 12: additive effects of interleukin 15 and 7.

Authors:  G Monteleone; T Parrello; F Luzza; F Pallone
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

5.  An insertion-deletion polymorphism in the interferon regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases.

Authors:  Vinciane Dideberg; Gudlaug Kristjansdottir; Lili Milani; Cécile Libioulle; Snaevar Sigurdsson; Edouard Louis; Ann-Christin Wiman; Séverine Vermeire; Paul Rutgeerts; Jacques Belaiche; Denis Franchimont; André Van Gossum; Vincent Bours; Ann-Christine Syvänen
Journal:  Hum Mol Genet       Date:  2007-09-19       Impact factor: 6.150

6.  The K/BxN arthritis model.

Authors:  Paul A Monach; Diane Mathis; Christophe Benoist
Journal:  Curr Protoc Immunol       Date:  2008-05

7.  Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus.

Authors:  Robert R Graham; Chieko Kyogoku; Snaevar Sigurdsson; Irina A Vlasova; Leela R L Davies; Emily C Baechler; Robert M Plenge; Thearith Koeuth; Ward A Ortmann; Geoffrey Hom; Jason W Bauer; Clarence Gillett; Noel Burtt; Deborah S Cunninghame Graham; Robert Onofrio; Michelle Petri; Iva Gunnarsson; Elisabet Svenungsson; Lars Rönnblom; Gunnel Nordmark; Peter K Gregersen; Kathy Moser; Patrick M Gaffney; Lindsey A Criswell; Timothy J Vyse; Ann-Christine Syvänen; Paul R Bohjanen; Mark J Daly; Timothy W Behrens; David Altshuler
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-05       Impact factor: 11.205

8.  A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk.

Authors:  Matthias Heinig; Enrico Petretto; Chris Wallace; Leonardo Bottolo; Maxime Rotival; Han Lu; Yoyo Li; Rizwan Sarwar; Sarah R Langley; Anja Bauerfeind; Oliver Hummel; Young-Ae Lee; Svetlana Paskas; Carola Rintisch; Kathrin Saar; Jason Cooper; Rachel Buchan; Elizabeth E Gray; Jason G Cyster; Jeanette Erdmann; Christian Hengstenberg; Seraya Maouche; Willem H Ouwehand; Catherine M Rice; Nilesh J Samani; Heribert Schunkert; Alison H Goodall; Herbert Schulz; Helge G Roider; Martin Vingron; Stefan Blankenberg; Thomas Münzel; Tanja Zeller; Silke Szymczak; Andreas Ziegler; Laurence Tiret; Deborah J Smyth; Michal Pravenec; Timothy J Aitman; Francois Cambien; David Clayton; John A Todd; Norbert Hubner; Stuart A Cook
Journal:  Nature       Date:  2010-09-08       Impact factor: 49.962

9.  Global H4 acetylation analysis by ChIP-chip in systemic lupus erythematosus monocytes.

Authors:  Z Zhang; L Song; K Maurer; M A Petri; K E Sullivan
Journal:  Genes Immun       Date:  2009-08-27       Impact factor: 2.676

10.  The systemic lupus erythematosus IRF5 risk haplotype is associated with systemic sclerosis.

Authors:  F David Carmona; Jose-Ezequiel Martin; Lorenzo Beretta; Carmen P Simeón; Patricia E Carreira; José Luis Callejas; Mónica Fernández-Castro; Luis Sáez-Comet; Emma Beltrán; María Teresa Camps; María Victoria Egurbide; Paolo Airó; Raffaella Scorza; Claudio Lunardi; Nicolas Hunzelmann; Gabriela Riemekasten; Torsten Witte; Alexander Kreuter; Jörg H W Distler; Rajan Madhok; Paul Shiels; Jacob M van Laar; Carmen Fonseca; Christopher Denton; Ariane Herrick; Jane Worthington; Annemie J Schuerwegh; Madelon C Vonk; Alexandre E Voskuyl; Timothy R D J Radstake; Javier Martín
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

View more
  14 in total

1.  A new transcription factor ATG10S activates IFNL2 transcription by binding at an IRF1 site in HepG2 cells.

Authors:  Miao-Qing Zhang; Qiong Zhao; Jing-Pu Zhang
Journal:  Autophagy       Date:  2020-01-29       Impact factor: 16.016

2.  Monocytes of newly diagnosed juvenile DM1 patients are prone to differentiate into regulatory IL-10+ M2 macrophages.

Authors:  Ulana Juhas; Monika Ryba-Stanisławowska; Agnieszka Brandt-Varma; Małgorzata Myśliwiec; Jolanta Myśliwska
Journal:  Immunol Res       Date:  2019-02       Impact factor: 2.829

Review 3.  Type I Interferons in Autoimmunity.

Authors:  Ruth Fernandez-Ruiz; Timothy B Niewold
Journal:  J Invest Dermatol       Date:  2022-01-10       Impact factor: 8.551

4.  [Regulatory mechanism of interferon regulatory factor 1 by α-synuclein in mouse Parkinson's disease model].

Authors:  F Mu; X Chen; X DU; Q Jiao; M Bi; H Jiang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-11-20

5.  Aim2 Couples With Ube2i for Sumoylation-Mediated Repression of Interferon Signatures in Systemic Lupus Erythematosus.

Authors:  Ailing Lu; Shuxian Wu; Junling Niu; Mengmeng Cui; Mengdan Chen; William L Clapp; Betsy J Barnes; Guangxun Meng
Journal:  Arthritis Rheumatol       Date:  2021-07-07       Impact factor: 15.483

Review 6.  Synergistic Activation of Toll-Like and NOD Receptors by Complementary Antigens as Facilitators of Autoimmune Disease: Review, Model and Novel Predictions.

Authors:  Robert Root-Bernstein
Journal:  Int J Mol Sci       Date:  2020-06-30       Impact factor: 5.923

Review 7.  Therapeutic Targeting of IRFs: Pathway-Dependence or Structure-Based?

Authors:  Cherrie D Thompson; Bharati Matta; Betsy J Barnes
Journal:  Front Immunol       Date:  2018-11-20       Impact factor: 7.561

Review 8.  Genetic Versus Non-genetic Drivers of SLE: Implications of IRF5 Dysregulation in Both Roads Leading to SLE.

Authors:  Betsy J Barnes
Journal:  Curr Rheumatol Rep       Date:  2019-01-15       Impact factor: 4.592

9.  Inhibition of IRF5 hyperactivation protects from lupus onset and severity.

Authors:  Su Song; Saurav De; Victoria Nelson; Samin Chopra; Margaret LaPan; Kyle Kampta; Shan Sun; Mingzhu He; Cherrie D Thompson; Dan Li; Tiffany Shih; Natalie Tan; Yousef Al-Abed; Eugenio Capitle; Cynthia Aranow; Meggan Mackay; William L Clapp; Betsy J Barnes
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

10.  Regulation of age-associated B cells by IRF5 in systemic autoimmunity.

Authors:  Michela Manni; Sanjay Gupta; Edd Ricker; Yurii Chinenov; Sung Ho Park; Man Shi; Tania Pannellini; Rolf Jessberger; Lionel B Ivashkiv; Alessandra B Pernis
Journal:  Nat Immunol       Date:  2018-02-26       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.